CD8A and neoplasm: Deletion of AMPK in T cells resulted in a decreased production of IFNγ and granzyme B as well as an elevated serine/protein phosphatase activity upon activation, resulting in decreased survival rates and anti-tumor functions of CD8+ T cells, which could be reversed by inhibition of phosphatase activity (41).